Title: Living cell technologies: finding a path to market for xenotransplantation therapy

Authors: Lisa Callagher; Brian Karlson; Nadine France; Cristiano Bellavitis

Addresses: Department of Management and International Business, Auckland Business School, 12 Grafton Road, Auckland, New Zealand ' Department of Management and International Business, Auckland Business School, 12 Grafton Road, Auckland, New Zealand ' Department of Management and International Business, Auckland Business School, 12 Grafton Road, Auckland, New Zealand ' Department of Management and International Business, Auckland Business School, 12 Grafton Road, Auckland, New Zealand

Abstract: This case examines the research commercialisation process of biotech company living cell technologies (LCT). The case outlines the process of pre-clinical and clinical trials undertaken by the company as they moved towards commercialising their pig islet cell treatment for Type 1 diabetes including the R&D and manufacturing capabilities the firm has developed. Also, the case describes the challenges in bringing a sometimes controversial biotech product to market, including regulatory hurdles; rapid changes to legislation; the impact of public opinion; and the difficulties in raising capital, maintaining cash flow and developing a pipeline of opportunities over a long period of commercialisation.

Keywords: research commercialisation; entrepreneurial finance; joint venture; R&D; case study.

DOI: 10.1504/IJTTC.2018.092640

International Journal of Technology Transfer and Commercialisation, 2018 Vol.16 No.1, pp.37 - 60

Received: 21 Jun 2017
Accepted: 24 Nov 2017
Published online: 26 Jun 2018 *

Full-text access for editors Full-text access for subscribers Purchase this article Comment on this article